Booth, L., Roberts, J. L., Poklepovic, A., Avogadri-Connors, F., Cutler, R. E., Lalani, A. S., & Dent, P. (2017). HDAC inhibitors enhance neratinib activity and when combined enhance the actions of an anti-PD-1 immunomodulatory antibody in vivo. Oncotarget.

Booth, Laurence, Jane L. Roberts, Andrew Poklepovic, Francesca Avogadri-Connors, Richard E. Cutler, Alshad S. Lalani, and Paul Dent. "HDAC Inhibitors Enhance Neratinib Activity and When Combined Enhance the Actions of an Anti-PD-1 Immunomodulatory Antibody in Vivo." Oncotarget 2017.

Booth, Laurence, et al. "HDAC Inhibitors Enhance Neratinib Activity and When Combined Enhance the Actions of an Anti-PD-1 Immunomodulatory Antibody in Vivo." Oncotarget 2017.